-
Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China
17 Feb 2026 16:50 GMT
… small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer … non-small cell lung cancer in Korea. Transl Lung Cancer Res … small cell lung cancer in Korea: updated survival data. Transl Lung Cancer … evolution of lung cancers acquiring resistance …
-
Johnson & Johnson's New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner
17 Feb 2026 17:29 GMT
… receptor (EGFR)-mutated advanced non-small cell lung cancer (NSCLC), monthly dosing delivers consistent … factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).
Rybrevant Faspro is … the 2025 World Conference on Lung Cancer (WCLC), PALOMA-2 data …
-
Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients
17 Feb 2026 13:00 GMT
… patients with early-stage non-small cell lung cancer.
Lung Cancer Trial Shows Benefit
The LIBRETTO … with RET fusion-positive non-small cell lung cancer.
This trial is the first … the treatment of early-stage lung cancer.
The broader market experienced a …
-
Clinicopathological and Genomic Analysis of SMARCA4-Deficient Non-Small Cell Lung Cancer: A Retrospective Cohort Study
16 Feb 2026 13:41 GMT
… subtype of non-small cell lung cancer (NSCLC) characterized … lymphocytes in non-small cell lung cancer. Cancer Lett. … resistance in non-small cell lung cancer: the role of … SMARCA4-deficient non-small cell lung cancer. Transl Lung Cancer Res. 2025; …
-
Quick at home ‘finger test’ can spot early signs of lung cancer
17 Feb 2026 02:48 GMT
… with non-small cell lung cancer and four percent of those with small cell lung cancer', … according to the Roy Castle Lung Cancer Foundation.
… chief executive of Roy Castle Lung Cancer Foundation comments:
"It’ …
-
Preliminary Exploration of Fluvastatin Inhibiting Proliferation, Migration and Invasion of Lung Cancer Cells and Reversing Paclitaxel Resistance: Mechanism Exploration Based on Multi-Omics Analysis
16 Feb 2026 07:38 GMT
… Lung cancer is classified into small cell lung cancer and non-small cell lung cancer … small cell lung cancer: current treatment and future advances. Transl Lung Cancer … non-small cell lung cancer. Lung Cancer. 2015 … for lung cancer therapy. Lung Cancer. 2011 …
-
Real-World Outcomes and Safety of PD-1 Blockade Rechallenge Strategies After Prior Immunotherapy in Advanced NSCLC: A Retrospective Cohort Study
17 Feb 2026 16:50 GMT
… small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancers … in advanced non-small cell lung cancer: new frontiers, … -small cell lung cancer: a retrospective exploratory study. Lung Cancer. … for advanced non-small cell lung cancer: a bicentric …
-
Lilly's rare cancer drug Retevmo looks to broaden reach with adjuvant trial win
17 Feb 2026 16:11 GMT
… IIIA) RET fusion-positive non-small cell lung cancer (NSCLC). The twice-daily … for targeted adjuvant therapy in lung cancer.”
The trial, which enrolled … about 85% of all lung cancer diagnoses in the U. … EGFR- and ALK-driven lung cancer, we hope these results …
-
Engineering the next generation of T-cell engagers
17 Feb 2026 16:16 GMT
… of a TCE to treat small cell lung cancer.[10] By deploying new engineering …
-
P-Cure announces first-ever prospective clinical results of gantry-less upright proton therapy for lung cancer re-irradiation
12 Feb 2026 18:09 GMT
… a challenge particularly pronounced in lung cancer patients, who often present with … the majority diagnosed with non-small cell lung cancer, all of whom had previously … a particularly significant finding in lung cancer, where treatment-related morbidity often …
About
© 1995-2026